PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Silymarin: An option to treat non-alcoholic fatty liver disease.

Abstract We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation.
PMID
Related Publications

Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.

Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series.

Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.

Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.

Non-alcoholic fatty liver disease and beneficial effects of dietary supplements.

Authors

Mayor MeshTerms

Non-alcoholic Fatty Liver Disease

Silymarin

Keywords

Antioxidant

Mediterranean diet

Non-alcoholic fatty liver disease

Silymarin

Journal Title world journal of gastroenterology
Publication Year Start




PMID- 29309065
OWN - NLM
STAT- MEDLINE
DCOM- 20180109
LR  - 20180110
IS  - 2219-2840 (Electronic)
IS  - 1007-9327 (Linking)
VI  - 23
IP  - 47
DP  - 2017 Dec 21
TI  - Silymarin: An option to treat non-alcoholic fatty liver disease.
PG  - 8437-8438
LID - 10.3748/wjg.v23.i47.8437 [doi]
AB  - We have read with a great interest the review published by Singh et al, on the
      treatment options in alcoholic and non-alcoholic fatty liver disease, including
      various new targeted therapies that are currently under investigation. Recently, 
      we described the health effects of the Mediterranean diet associated to an
      antioxidant complex rich in silymarin, to improve in overweight patients
      anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat
      accumulation.
FAU - Colica, Carmela
AU  - Colica C
AD  - CNR, IBFM UOS of Germaneto, University "Magna Graecia", Catanzaro 88100, Italy.
FAU - Boccuto, Luigi
AU  - Boccuto L
AD  - Research Department, Greenwood Genetic Center, School of Health Research, Clemson
      University, Greenwood 29646, United States.
FAU - Abenavoli, Ludovico
AU  - Abenavoli L
AD  - Department of Health Sciences, University Magna Graecia, Campus Germaneto, Viale 
      Europa, Catanzaro 88100, Italy. [email protected]
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - World J Gastroenterol
JT  - World journal of gastroenterology
JID - 100883448
RN  - 0 (Antioxidants)
RN  - 0 (Silymarin)
SB  - IM
CON - World J Gastroenterol. 2017 Sep 28;23 (36):6549-6570. PMID: 29085205
MH  - Antioxidants
MH  - Humans
MH  - Lipid Metabolism
MH  - *Non-alcoholic Fatty Liver Disease
MH  - Overweight
MH  - *Silymarin
PMC - PMC5743515
OTO - NOTNLM
OT  - Antioxidant
OT  - Mediterranean diet
OT  - Non-alcoholic fatty liver disease
OT  - Silymarin
COIS- Conflict-of-interest statement: Authors declares no conflict of interest related 
      to this publication.
EDAT- 2018/01/09 06:00
MHDA- 2018/01/10 06:00
CRDT- 2018/01/09 06:00
PHST- 2017/11/08 00:00 [received]
PHST- 2017/11/27 00:00 [revised]
PHST- 2017/12/04 00:00 [accepted]
PHST- 2018/01/09 06:00 [entrez]
PHST- 2018/01/09 06:00 [pubmed]
PHST- 2018/01/10 06:00 [medline]
AID - 10.3748/wjg.v23.i47.8437 [doi]
PST - ppublish
SO  - World J Gastroenterol. 2017 Dec 21;23(47):8437-8438. doi:
      10.3748/wjg.v23.i47.8437.